UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 6
June-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1907C33


Registration ID:
221208

Page Number

492-499

Share This Article


Jetir RMS

Title

Method Development and Validation of Irbesartan by RP-HPLC Method

Abstract

This study includes development of RP-HPLC method for estimation of Irbesartan. The developed method was validated as per ICH guidelines in terms of specificity, accuracy, linearity, LOD, LOQ, ruggedness and robustness. The inter-day and intra-day precision results were good enough to indicate that the proposed method was precise and reproducible. The assay experiment showed that the contents of Irbesartan estimated in the tablet dosage were free from interference of excipients, which indicate that developed method was specific. Recovery of standard added drugs was found to be 97.2-99.9% for Irbesartan indicating that the proposed method was accurate. A good linear relationship was observed for standard drug of Irbesartan and tablet form of Irbesartan in the concentration ranges of 60 – 100 µ/ml . The correlation coefficient for Irbesartan was found to be 0.998 µ/ml. After performing analysis by different analyst; it was found that the RP-HPLC method for the determination of Irbesartan was found to be rugged. % RSD for robustness was well within the limits ensuring that the proposed method was robust. The LOD was 0.710 µ/ml for standard drug of Irbesartan. For standard drug of Irbesartan the LOQ were found to be 0.116 µ/ml This demonstrated that the developed RP-HPLC method was simple, linear, precise, accurate, robust and rugged, could be conveniently adopted for the routine quality control analysis of Irbesartan from it’s pharmaceutical dosage form and bulk drug.

Key Words

Irbesartan,RP-HPLC

Cite This Article

"Method Development and Validation of Irbesartan by RP-HPLC Method", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.492-499, June 2019, Available :http://www.jetir.org/papers/JETIR1907C33.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Method Development and Validation of Irbesartan by RP-HPLC Method", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp492-499, June 2019, Available at : http://www.jetir.org/papers/JETIR1907C33.pdf

Publication Details

Published Paper ID: JETIR1907C33
Registration ID: 221208
Published In: Volume 6 | Issue 6 | Year June-2019
DOI (Digital Object Identifier):
Page No: 492-499
Country: ahmednagar, maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002806

Print This Page

Current Call For Paper

Jetir RMS